Filing Details

Accession Number:
0001213900-17-006880
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-28 11:30:17
Reporting Period:
2017-06-26
Filing Date:
2017-06-28
Accepted Time:
2017-06-28 11:30:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1498382 Delmar Pharmaceuticals Inc. DMPI Pharmaceutical Preparations (2834) 990360497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569585 K John Bell Suite 720-999 West Broadway
Vancouver A1 V5Z 1K5
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-26 4,167 $3.60 49,455 No 4 P Indirect Note
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Note
Footnotes
  1. The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $20,000. Reported price is based on exchange rate of 0.75.
  2. Shares are held by Onbelay Capital Inc.